The opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country.
As opioid abuse rates have skyrocketed, new Hepatitis C infections have also increased. Data on HepVu show that an estimated 4 million Americans were living with Hepatitis C between 2013 and 2016. Though the majority, or roughly three-fourths, of all infections were among Baby Boomers (those born between 1945 and 1965), there has been a spike in new Hepatitis C infections among younger Americans.
The number of new Hepatitis C infections more than doubled from 2012 to 2019, largely reflecting infections due to the rise in injection drug use. This has created a syndemic, in which the opioid and Hepatitis C epidemics are linked – with the burden of Hepatitis C being directly exacerbated by injection drug use.
The Opioid Epidemic
In 2017, the U.S. Department of Health and Human Services (HHS) declared a public health state of emergency due to the opioid epidemic. Opioids are highly addictive and include prescription pain relievers, synthetic compounds such as fentanyl, and illegal drugs such as heroin. More than 106,000 persons in the U.S. died from drug-involved overdose in 2021, including illicit drugs and prescription opioids. Opioid-involved overdose deaths rose from 21,089 in 2010 to 47,600 in 2017 and remained steady through 2019. This was followed by a significant increase in 2020 with 68,630 reported deaths and again in 2021 with 80,411 reported overdose deaths.
The opioid epidemic’s growth even contributed to a decrease in annual U.S. life expectancy, which declined to 77.3 years in 2020 primarily be attributed to deaths from the COVID-19 pandemic, although drug overdose deaths accounted for over one-third of all unintentional injury deaths.
Key Insights:
- In 2021, 8 of the top 10 states with the highest opioid prescription rate were in the South
- In 2021, 4 of the top 5 states with the highest percentage of pain reliever misuse were in the South.
- In 2021, 7 of the top 10 states with the highest rates of narcotic overdose deaths were in the South.
- In 2020, all top 10 counties with the highest rates Hepatitis C Mortality were in the South
- In 2020, all top 10 states with the highest rates of Hepatitis C mortality are either in the South or West
- In 2021, 8 of the top 10 counties with the highest rates of narcotic overdose deaths were in West Virginia
- The top 3 states with the highest percent increase in narcotic overdose deaths from 2020 to 2021 were Alaska, Oregon, and Kansas.
- There were 3 states that saw a decrease in the rate of narcotic overdose deaths from 2020 to 2021: Hawaii, Nebraska, and Maryland.
The HIV and Hepatitis C Syndemic
A syndemic refers to two or more interrelated epidemics that are mutually reinforcing and interact in a way that amplifies the overall burden of disease. Although not all people who abuse opioids inject drugs, people who inject drugs are at significantly higher risk of transmission of blood-borne viruses, including HIV and Hepatitis C.
Hepatitis C and HIV can be transmitted by sharing needles, syringes, water, alcohol swabs, and other equipment used to inject drugs. In 62-80% of people who inject drugs co-infection with HIV and Hepatitis C is common. As younger Americans engage in injection drug use, there is also a greater risk of women of childbearing age contracting Hepatitis C and pregnant women exposing their babies to the virus.
The Centers for Disease Control and Prevention (CDC) recommends routine HIV and viral hepatitis screening for people who inject drugs. Additionally, prevention efforts, such as syringe service programs and substance use treatment services, can slow the growth in the number of new Hepatitis C and HIV infections due to injection drug use. By identifying new infections early, patients can be treated for HIV, or cured of Hepatitis C, and stop additional infections from occurring.
People with HIV and Hepatitis B
Hepatitis B virus (HBV) and HIV are bloodborne viruses transmitted primarily through sexual contact and injection-drug use. Because of these shared modes of transmission, a high proportion of adults at risk for HIV infection are also at risk for HBV infection. People with HIV who become infected with HBV are at increased risk for liver-related morbidity and mortality.
4 Ways to Use HepVu
Explore Interactive Maps
View Local Statistics
View local statistics for your state, and download high-impact data visualizations for your work
See the DataDownload Data
See the DataLearn From Experts
Experts weigh in on the opioid epidemic and the resulting syndemic in HepVu’s blog series.
August 23, 2021
Dr. Eric Hall on County-Level Opioid Prescribing and Overdose Mortality Rates
Eric Hall, PhD, MPH, is a Postdoctoral Researcher for the Department of Epidemiology at Emory University’s Rollins School of Public Health. Q: Your research focuses on county-level overdose mortality and opioid prescription rates. Can you explain what these rates mean and how they relate to the viral hepatitis epidemic in the U.S.? Over the
Read MoreMarch 25, 2021
Dr. Gregory Dore on Hepatitis C Treatment Barriers Among People Who Inject Drugs
Gregory Dore, MD is a Scientia Professor and the Head of Viral Hepatitis Clinical Research Program at the Kirby Institute at the University of New South Wales Sydney in Australia. Q: Your career focuses on Hepatitis C and other infectious diseases, especially among marginalized populations such as people who use drugs and people who experience homelessness.
Read MoreMarch 18, 2021
Injection Drug Use and Hepatitis C Trends in the Indian Health Service
Richard Haverkate, MPH, is the National HIV/HCV Program Coordinator for the Indian Health Service. Q: In July 2020, you co-authored a study that analyzed trends in indicators of injection drug use (IDU) using data from the Indian Health Service inpatient and outpatient database from 2010-2014. What specific indicators did you select as proxies for injection drug use, and
Read MoreApril 21, 2020
Vu Q&A: Dr. Elinore McCance-Katz on Opioid Use Disorder
Elinore McCance-Katz, MD, PhD, is the first assistant secretary for mental health and substance use and leads the Substance Abuse and Mental Health Services Administration (SAMHSA). Q: In 2017, you were nominated as the first Assistant Secretary for Mental Health and Substance Use and now lead the Substance Abuse and Mental Health Services Administration (SAMHSA).
Read MoreJanuary 15, 2019
Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.
Heather Bradley, Ph.D., is an Assistant Professor of Epidemiology at Georgia State University and serves as HepVu Project Director. Ron Valdiserri, M.D., MPH, is Senior Research Associate and Distinguished Scholar, Johns Hopkins University, Bloomberg School of Public Health, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services, and serves
Read MoreMay 29, 2018
Vu Q&A: The Opioid Epidemic and Viral Hepatitis in Appalachia
Judith Feinberg has a joint appointment in the West Virginia University School of Medicine as a professor of Behavioral Medicine & Psychiatry and Medicine/Infectious Diseases. She is the Vice Chair of the HIV Medicine Association and a nationally-recognized expert on the opioid epidemic in West Virginia, Appalachia and rural America. Q: The number of new
Read MoreJanuary 10, 2018
Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic
The other important component of the U.S. Hepatitis C epidemic is smaller in absolute numbers but is the major source of new Hepatitis C infections: infections associated with the opioid epidemic, injection drug use, and the sharing of needles and other drug injection equipment.
Read MoreFor More Information
Additional information about the opioid and Hepatitis C epidemics can be found at the following resources.
U.S. Centers for Disease Control and Prevention
Opioid Overdose: Understanding the Epidemic
Learn MoreU.S. Centers for Disease Control and Prevention
Increase in hepatitis C infections linked to worsening opioid crisis
Learn MoreSurgeon General
Facing Addition in America: The Surgeon General’s Spotlight on Opioids (PDF)
Learn More